DAVIDSON MICHAEL H. (Chief Executive Officer) sold 3.0% of their position (12.26K shares) of NEWAMSTERDAM PHARMA CO N.V. on the open market
Insider sale on the open market — a minor trim. Check remaining position size for full context.
S · 1 sale
Filed: 3/28/2025ACC: 0000950170-25-046934
DirectorOfficer· Chief Executive Officer
Since Mar 2026
+57.13K
Net shares
Net buyer
$0.00
Total acquired
1
Open market trades
0B · 1S
5
Total transactions
107.78K acquired · 50.65K disposed
Non-Derivative Transactions3
Ordinary Shares
Direct
Shares
+30.99K
Price / share
—
Trade value
—
% of position
9.3%
3/26/2025
333.31K→364.31K
Ordinary Shares
Direct
Shares
+38.39K
Price / share
—
Trade value
—
% of position
10.5%
3/26/2025
364.31K→402.70K
Ordinary Shares
Direct
Shares
−12.26K
Price / share
—
Trade value
—
% of position
3.0%
3/26/2025
402.70K→390.44K
Total
Net shares
+57.13K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 3/26/2025 | A · Award | +30.99K | — | — | 9.3% | 333.31K | 364.31K |
| Ordinary Shares Direct | 3/26/2025 | M · Option Exercise | +38.39K | — | — | 10.5% | 364.31K | 402.70K |
| Ordinary Shares Direct | 3/26/2025 | S · Sale | −12.26K | — | — | 3.0% | 402.70K | 390.44K |
| Total | +57.13K | $0.00 | ||||||
Derivative Transactions2
Restricted Stock Unit
Direct
Converts to
Ordinary Shares
38.39K shares
Shares
+38.39K
Strike price
Held after
38.39K
Exercisable
—
3/26/2025
Restricted Stock Unit
Direct
Converts to
Ordinary Shares
38.39K shares
Shares
−38.39K
Strike price
Held after
0.00
Exercisable
—
3/26/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Unit Direct | Ordinary Shares38.39K shares | 3/26/2025 | A · Award | +38.39K | — | 38.39K | |
| Restricted Stock Unit Direct | Ordinary Shares38.39K shares | 3/26/2025 | M · Option Exercise | −38.39K | — | 0.00 |